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Purpose of the study
To evaluate if prognosis of HIV infection, after the inci-
dence of first AIDS-defining condition, is becoming better
with improvement in HIV infection management proto-
cols.
Methods
The COMESEM cohort registers any HIV-infected patient
receiving care in any of a group of several general commu-
nity hospitals responsible for global medical care to a
population close to 1,600,000 inhabitants of Madrid's
perimetropolitan area. In the actuality it registers 8,166
HIV-infected patients, with a follow-up of 42,148 patient-
years. We included in the study any patient with a recent
diagnosis of HIV infection (less than 6 months) who suf-
fered a first AIDS-defining disease. Survival was measured
with Kaplan-Meier test, and differences and hazard ratios
between 4-yearly periods after 1996 (1996–1999, 2000–
2003 and 2004–2008) were measured with Maentel-
Haenzel's log-rank and Cox-regression tests.
Summary of results
3,987 patients included in the COMESEM cohort were
recently diagnosed of HIV infection. 1,270 of them expe-
rienced first incidence of AIDS-defining condition, 603
after January 1, 1996. Most frequent diagnosed patholo-
gies were tuberculosis (27.1%), P. jirovecii pneumonia
(21.5%), and oro-oesophageal candidiasis (13.4%).
Median survivals after first AIDS-defining condition in
any of the evaluated periods in the HAART era were largely
greater than 10 years, much longer than in the pre-HAART
years (p < 0.0001). There were no significant differences
in survival between 1996–1999 and 2000–2003 (p =
0.214). Nevertheless, survival was significantly better in
period 2004–2008 vs. any of both previous periods 1996–
1999 (HR = 2,905, 95% CI 1,620–5,208) or 2000–2003
(HR = 2,581, 95% CI 1,393–4,784). (Table 1.)
Conclusion
Prognosis of HIV-infected patients after incidence of first
AIDS-defining condition is becoming increasingly better
in recent years, probably reflecting improvements in HIV
infection treatment protocols.
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Events Events Survival Survival Survival Hazard Ratio Hazard Ratio Log-rank
Period Patients "n" % p-25% median p-75% HR IC.95% "P"
1996–99 306 129 42,6 ND ND 1,673 1 (reference category)
2000–03 191 53 27,7 ND ND 2,669 1,230 0,887 – 1,706 =,214
2004–08 164 13 7,9 ND ND ND 2,905 1,620 – 5,208 <,0001
........
2000–03 191 53 27,7 ND ND 2,669 1 (reference category)
2004–08 164 13 7,9 ND ND ND 2,581 1,393 – 5,208 =,001
.........
ND – not determinable (not afforded in the population studied).Page 2 of 2
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